Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
20.27
-0.09 (-0.44%)
Aug 29, 2025, 4:00 PM - Market closed

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.20 billion. The enterprise value is $710.78 million.

Market Cap1.20B
Enterprise Value 710.78M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

ELVN has 59.24 million shares outstanding. The number of shares has increased by 16.08% in one year.

Current Share Class 59.24M
Shares Outstanding 59.24M
Shares Change (YoY) +16.08%
Shares Change (QoQ) +4.10%
Owned by Insiders (%) 4.26%
Owned by Institutions (%) 67.80%
Float 36.32M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.46
P/TBV Ratio 2.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 32.58, with a Debt / Equity ratio of 0.00.

Current Ratio 32.58
Quick Ratio 32.25
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -25.26% and return on invested capital (ROIC) is -17.98%.

Return on Equity (ROE) -25.26%
Return on Assets (ROA) -17.19%
Return on Invested Capital (ROIC) -17.98%
Return on Capital Employed (ROCE) -23.38%
Revenue Per Employee n/a
Profits Per Employee -$1.62M
Employee Count62
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.51% in the last 52 weeks. The beta is 1.03, so ELVN's price volatility has been similar to the market average.

Beta (5Y) 1.03
52-Week Price Change -9.51%
50-Day Moving Average 20.47
200-Day Moving Average 20.94
Relative Strength Index (RSI) 51.82
Average Volume (20 Days) 424,153

Short Selling Information

The latest short interest is 4.94 million, so 8.35% of the outstanding shares have been sold short.

Short Interest 4.94M
Short Previous Month 5.08M
Short % of Shares Out 8.35%
Short % of Float 13.61%
Short Ratio (days to cover) 13.04

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -114.24M
Pretax Income -79.60M
Net Income -100.22M
EBITDA -113.93M
EBIT -114.24M
Earnings Per Share (EPS) -$2.00
Full Income Statement

Balance Sheet

The company has $490.50 million in cash and $580,000 in debt, giving a net cash position of $489.92 million or $8.27 per share.

Cash & Cash Equivalents 490.50M
Total Debt 580,000
Net Cash 489.92M
Net Cash Per Share $8.27
Equity (Book Value) 488.47M
Book Value Per Share 8.25
Working Capital 480.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$70.58 million and capital expenditures -$181,000, giving a free cash flow of -$70.76 million.

Operating Cash Flow -70.58M
Capital Expenditures -181,000
Free Cash Flow -70.76M
FCF Per Share -$1.19
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.08%
Shareholder Yield -16.08%
Earnings Yield -8.35%
FCF Yield -5.89%

Analyst Forecast

The average price target for ELVN is $41.20, which is 103.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target $41.20
Price Target Difference 103.26%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -5.20%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2